TUF-11022-94397
4 vaccinations
3 coded responses
37 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 945 / CA
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Pfizer-BioNTech
- 2020-12-31
-
2021-01-01
Survey response — days 1–6 daily, dose 1MedDRA: Pruritus — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Itchiness on toes, legs, arms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-02
Survey response — days 1–6 daily, dose 1MedDRA: Pruritus — Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteFree text: Itchy toes.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-07
- 2021-01-16
-
2021-01-20
Dose 2 — Pfizer-BioNTech
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-04-21
- 2021-07-21
-
2021-10-14
Dose 3 — Pfizer-BioNTech
- 2022-01-20
-
2022-04-20
Dose 4 — Pfizer-BioNTech
-
2022-04-21
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-04-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-04-23
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-04-24
- 2022-04-25
- 2022-04-26
- 2022-04-27
- 2022-05-04
- 2022-05-11
- 2022-05-18
- 2022-05-25
- 2022-07-20
-
2022-10-19
Survey response — 6 months, dose 4MedDRA: Loss of consciousness, Syncope — Feeling: Good · Be unable to work or attend schoolFree text: Episode of Syncope (fainted, loss of consciousness) 12 hours after administration 5th booster of Pfizer VaccineMedDRA releases: 2024-11 · check-in free text available
- 2023-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | No |
| 4 | 2022-04-20 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Itchiness on toes, legs, arms.
Systemic reaction (other): Itchy toes.
Release 12 — 6 months, dose 4
Symptoms: Episode of Syncope (fainted, loss of consciousness) 12 hours after administration 5th booster of Pfizer Vaccine
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Loss of consciousness | · | · | ✓ |
| SD | Syncope | · | · | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release